ArticleJournal of primary care & community health
Prevalence and Characteristics of Febrile Seizures in COVID-19 Pandemic in Thailand: A Tertiary Medical-Center Retrospective Study.
Article in Journal of primary care & community health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundFebrile seizures (FS) are often associated with viral infections. COVID-19 infection may be related to FS. The objective is to evaluate the prevalence and characteristics of FS during COVID-19 period.MethodsThis retrospective study of children aged 6-60 months with FS or COVID-19 infection was conducted at a tertiary hospital from January 2020 to November 2023, categorized by pre-Omicron, transition, and Omicron periods. Data from all FS and COVID-19 cases were descriptively analyzed using mean or median, and compared across three periods using ANOVA. The characteristics of FS with and without COVID-19 patients, as well as COVID-19 with and without FS patients, were compared by using t-test or Wilcoxon rank-sum test.ResultsThe FS prevalence in COVID-19 patients was 0.36%, with age-specific prevalence of 1.31% in COVID-19 cases aged 6-60 months. Males were more prevalent in all FS groups. Generalized seizures and simple FS were the most common presentations. Thirty-three percent of FS with COVID-19 were complex febrile seizures, compared to 20% in non-COVID-19 cases. Cough was a significant symptom in COVID-19 without FS (p=0.03), while male, higher body temperature, pulse and respiratory rate were more prevalent in COVID-19 cases with FS (p <0.05).ConclusionsCOVID-19 does not increase the risk of FS compared to other causes. Male gender, higher body temperature, pulse and respiratory rate in COVID-19 children are associated with FS. Cough was a less relevant symptom for FS in COVID-19 children. Well-designed, large-scale research is needed to better understand FS in pediatric COVID-19 patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.